We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 30, 2021

Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among US Adults Hospitalized With COVID-19

Annals of Internal Medicine


Additional Info

Annals of Internal Medicine
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study
Ann. Intern. Med 2021 Aug 17;[EPub Ahead of Print], HB Mehta, H An, KM Andersen, O Mansour, V Madhira, ES Rashidi, B Bates, S Setoguchi, C Joseph, PT Kocis, R Moffitt, TD Bennett, CG Chute, BT Garibaldi, GC Alexander

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading